Aligos Therapeutics (ALGS) Revenue (2021 - 2026)
Aligos Therapeutics (ALGS) reported Revenue of $2.8 million for Q1 2026, up 809.97% on a YoY basis from $311000.0 in Q1 2025, and up 1574.56% quarter-over-quarter from $169000.0 in Q4 2025.
Aligos Therapeutics (ALGS) Revenue (2021 - 2026) Analysis & Trends
Aligos Therapeutics has reported Revenue for 6 years, with the latest figure at $2.8 million in Q1 2026.
- For the quarter ending Q1 2026, Revenue rose 809.97% year-over-year to $2.8 million; the trailing twelve-month figure through Mar 2026 stood at $4.7 million (up 45.76% YoY), and the FY2025 full-year result was $2.2 million, down 39.46% from the prior year.
- Revenue for Q1 2026 stood at $2.8 million, up from $169000.0 in the prior quarter.
- The five-year high for Revenue was $4.3 million in Q2 2023, with the low at $169000.0 in Q4 2025.
- Historically, Revenue has averaged $1.8 million across 5 years, with a median of $1.2 million in 2024.
- Annual changes were most pronounced in 2022 — Revenue jumped 863.76% — and 2024, when it plunged 84.13%.
- Aligos Therapeutics' Revenue stood at $3.5 million in 2022, then advanced by 7.97% to $3.8 million in 2023, then sank by 84.13% to $606000.0 in 2024, then sank by 72.11% to $169000.0 in 2025, then surged by 1574.56% to $2.8 million in 2026.
- The last three Revenue figures came in at $2.8 million (Q1 2026), $169000.0 (Q4 2025), and $741000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Aligos Therapeutics | 51.70 Mn | -28.13 Mn | - | 2.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.83 Mn |
| Dec 31, 2025 | 169,000.00 |
| Sep 30, 2025 | 741,000.00 |
| Jun 30, 2025 | 965,000.00 |
| Mar 31, 2025 | 311,000.00 |
| Dec 31, 2024 | 606,000.00 |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 1.06 Mn |
| Mar 31, 2024 | 694,000.00 |
| Dec 31, 2023 | 3.82 Mn |
| Sep 30, 2023 | 2.15 Mn |
| Jun 30, 2023 | 4.29 Mn |
| Mar 31, 2023 | 2.58 Mn |
| Dec 31, 2022 | 3.54 Mn |
| Mar 31, 2022 | 2.57 Mn |
| Dec 31, 2021 | 367,000.00 |
| Sep 30, 2021 | 1.54 Mn |
| Jun 30, 2021 | 1.55 Mn |
| Mar 31, 2021 | 910,000.00 |